Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by bazooka73on Jan 04, 2023 4:05am
335 Views
Post# 35202078

Q&A event

Q&A event
I really wonder what we can expect from this Q&A event. The management will hardly say more than they are allowed to (or even want to). And I rather don't see whether questions on answers will be allowed, which would make the whole thing exciting. I hope it doesn't mutate into a token event.
The only thing that will help Sirona's share price - and here I agree with many critical voices in this board - are numbers, numbers and again numbers.
It is absolutely incomprehensible to me why management isn't able provide at least a rudimentary financial forecast. They talk about Sirona becoming "profitable. But they still don't say what they mean by this. The same applies to personnel changes and how communication can be improved so that at least a certain credibility returns to the statements. Unfortunately, management still has a lot to answer for. But I still have very big doubts whether a Q&A event will change this.
 
 
<< Previous
Bullboard Posts
Next >>